CRISPR Therapeutics AG (LON:0VRQ)

Zuora Revenue

CRISPR Therapeutics AG had revenue of $865.00K USD in the quarter ending March 31, 2025, with 71.63% growth. This brings the company's revenue in the last twelve months to $37.68M, down -86.13% year-over-year. In the year 2024, CRISPR Therapeutics AG had annual revenue of $37.31M, down -89.95%.

• Revenue (ttm): $37.68M
• Revenue Growth: -86.13%
• P/S Ratio: 133.23
• Revenue / Employee: $95.87K
• Employees: 393
• Market Cap: 3.89B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.31M	-333.89M	-89.95%
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%
Dec 31, 2020	719.00K	-288.87M	-99.75%